Literature DB >> 21306785

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

Alan Menter, Neil J Korman, Craig A Elmets, Steven R Feldman, Joel M Gelfand, Kenneth B Gordon, Alice Gottlieb, John Y M Koo, Mark Lebwohl, Craig L Leonardi, Henry W Lim, Abby S Van Voorhees, Karl R Beutner, Caitriona Ryan, Reva Bhushan.   

Abstract

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In the first 5 parts of the American Academy of Dermatology Psoriasis Guidelines of Care, we have presented evidence supporting the use of topical treatments, phototherapy, traditional systemic agents, and biological therapies for patients with psoriasis and psoriatic arthritis. In this sixth and final section of the Psoriasis Guidelines of Care, we will present cases to illustrate how to practically use these guidelines in specific clinical scenarios. We will describe the approach to treating patients with psoriasis across the entire spectrum of this fascinating disease from mild to moderate to severe, with and without psoriatic arthritis, based on the 5 prior published guidelines. Although specific therapeutic recommendations are given for each of the cases presented, it is important that treatment be tailored to meet individual patients' needs. In addition, we will update the prior 5 guidelines and address gaps in research and care that currently exist, while making suggestions for further studies that could be performed to help address these limitations in our knowledge base.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306785     DOI: 10.1016/j.jaad.2010.11.055

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  107 in total

1.  Linear psoriasis.

Authors:  Wei Li; Xiao-Yong Man
Journal:  CMAJ       Date:  2012-02-06       Impact factor: 8.262

2.  American academy of dermatology, summer academy meeting.

Authors:  Takaharu Kato; Peter Sonnenreich
Journal:  P T       Date:  2011-11

Review 3.  Secukinumab: a promising therapeutic option in spondyloarthritis.

Authors:  Hernan Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2016-07-20       Impact factor: 2.980

Review 4.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

Review 5.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 6.  Diagnosis and management of psoriasis.

Authors:  Whan B Kim; Dana Jerome; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

7.  Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.

Authors:  Junko Takeshita; Shuwei Wang; Daniel B Shin; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Michael B Stierstorfer; Bruce A Brod; Stephen M Schleicher; Andrew D Robertson; Kristin A Linn; Russell T Shinohara; Andrea B Troxel; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2014-09-24       Impact factor: 11.527

Review 8.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

9.  Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05.

Authors:  Joseph F Fowler; James Q Del Rosso; Refika I Pakunlu; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

Review 10.  Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.

Authors:  Esther S Kim; James E Frampton
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.